# Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer

> **NCT00244933** · PHASE2 · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 19 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** genistein
- **DRUG:** gemcitabine
- **PROCEDURE:** Tumor biopsy

## Key facts

- **NCT ID:** NCT00244933
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2008-11
- **Final completion:** 2009-10
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244933, "Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00244933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*